FDA investigating rare allergic reactions to Pfizer coronavirus vaccine, but says rollout will continue – Washington Post

The FDA said it is closely monitoring these situations and is teaming with the Centers for Disease Control and Prevention to investigate what incited these responses. While that is being investigated, the FDA is working with Pfizer to update fact sheets and prescribing information to reflect the evolving information. The FDA said that would underscore an existing requirement that facilities administering the vaccine must be capable of immediately treating any severe allergic reaction.
The vaccine…

Click here to view the original article.